Absence of Inhibitor Development in the Routine Clinical Use of Alphanate® in Patients with Severe Hemophilia A: Results From a Long-Term Post-Marketing Surveillance Study Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sexauer, Charles L
  • Ayob, Yasmin
  • Cantini, Madeline
  • Escobar, Miguel Antonio
  • Fukuda, Tamiko
  • Holtz, Kristine
  • Manucci, Pier
  • Moynihan, Kathryn
  • Saxena, Kapil
  • Walsh, Christopher
  • Paez, Hector Antonio
  • Pinciaro, Paul P
  • Woodward, Michael Ken

publication date

  • November 20, 2009

published in